Open access
Open access
Powered by Google Translator Translator

Internal Medicine

Perspective: For Seniors, COVID-19 Sets Off A Pandemic Of Despair

29 May, 2020 | 03:23h | UTC

For Seniors, COVID-19 Sets Off A Pandemic Of Despair – Kaiser Health News

 


Observational Study: Many Patients with Covid-19 in the UCI Develop Thromboembolism Despite Routine Prophylaxis

29 May, 2020 | 03:17h | UTC

Routine Venous Thromboembolism Prophylaxis May Be Inadequate in the Hypercoagulable State of Severe Coronavirus Disease 2019 – Critical Care Medicine

 


International Consensus on the Diagnosis and Management of Dumping Syndrome

29 May, 2020 | 03:12h | UTC

International consensus on the diagnosis and management of dumping syndrome – Nature Reviews Endocrinology

 


Meta-Analysis: Direct Oral Anticoagulants vs. Low‐molecular‐weight Heparin for the Treatment of Cancer‐associated Thrombosis

29 May, 2020 | 03:03h | UTC

Direct oral anticoagulants compared to low‐molecular‐weight heparin for the treatment of cancer‐associated thrombosis: Updated systematic review and meta‐analysis of randomized controlled trials – Research and Practice in Thrombosis and Haemostasis

“In patients with cancer‐associated VTE, DOACs are more effective in preventing recurrent VTE compared to LMWH. However, risk of bleeding is increased with DOACs, especially in patients with GI cancer.”

 


[Abstract Only] Study: Repeat ANA Testing After a Negative Result has Low Utility and Results in High Cost

29 May, 2020 | 03:01h | UTC

Utility of repeated antinuclear antibody tests: a retrospective database study – The Lancet Rheumatology

 


WHO Interim Guidance: Clinical Management of COVID-19

28 May, 2020 | 10:02h | UTC

Clinical management of COVID-19 – World Health Organization

 


Systematic Review: Hydroxychloroquine or Chloroquine for Treatment or Prophylaxis of COVID-19

28 May, 2020 | 09:59h | UTC

Hydroxychloroquine or Chloroquine for Treatment or Prophylaxis of COVID-19: A Living Systematic Review – Annals of Internal Medicine

 


Remdesivir for Covid-19: A 5-day Course is Similarly Effective as a 10-day Course

28 May, 2020 | 10:00h | UTC

Remdesivir for 5 or 10 Days in Patients with Severe Covid-19 – New England Journal of Medicine

 


Perspective: Reducing Transmission of SARS-CoV-2

28 May, 2020 | 09:55h | UTC

Reducing transmission of SARS-CoV-2 – Science

 


Perspective: “The Unexpected Side Effect of Covid-19″

28 May, 2020 | 09:53h | UTC

The unexpected side effect of Covid-19 – CNN

“After Covid-19, if we dare imagine the day, it will be important to ask who was harmed by delayed and forgone medical care. But the severe financial strains on individuals and public budgets make it just as essential to ask who benefited from avoiding interventions with no salutatory effect.”

 


Study: No Evidence Blanket ‘Do-not-resuscitate’ Orders for COVID-19 Patients are Necessary

28 May, 2020 | 09:50h | UTC

No evidence blanket ‘do-not-resuscitate’ orders for COVID-19 patients are necessary – American Heart Association

Original Study: Survival After In-Hospital Cardiac Arrest In Critically Ill Patients: Implications For Covid-19 Outbreak? – Circulation: Cardiovascular Quality and Outcomes

 


Assessment of Proficiency of N95 Mask Donning Among the General Public in Singapore

28 May, 2020 | 09:44h | UTC

Assessment of Proficiency of N95 Mask Donning Among the General Public in Singapore – JAMA Network Open

Commentaries: People Are Still Terrible at Correctly Using Medical-Grade Face Masks And Respirators – Science Alert AND Study Casts Doubt on N95 Masks for the Public – MedPage Today (free registration required)

 


Randomized Trial: Comparison of 3 Treatment Strategies for Medication Overuse Headache

28 May, 2020 | 09:40h | UTC

Comparison of 3 Treatment Strategies for Medication Overuse Headache: A Randomized Clinical Trial – JAMA Neurology (free for a limited period)

 


EULAR Recommendations for the Management of Psoriatic Arthritis

28 May, 2020 | 09:31h | UTC

EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update – Annals of Rheumatic Diseases

Editorial: EULAR PsA management recommendations 2019: can the recommendations be improved?

Commentary: EULAR releases recommendations for PsA management – Medicine Matters

 


“Is It Safe for Me to Go to Work?” Risk Stratification for Workers during the Covid-19 Pandemic

27 May, 2020 | 02:39h | UTC

“Is It Safe for Me to Go to Work?” Risk Stratification for Workers during the Covid-19 Pandemic – New England Journal of Medicine

 


CDC Updated Guidance: When You Can be Around Others After You Had or Likely Had COVID-19

27 May, 2020 | 02:37h | UTC

When You Can be Around Others After You Had or Likely Had COVID-19 – Centers for Disease Control and Prevention

“I think or know I had COVID-19, and I had symptoms.”

You can be with others after:

  • 3 days with no fever AND
  • Symptoms improved AND
  • 10 days since symptoms first appeared”

 


Study: Loss of Smell and Taste in 2013 Patients with Mild to Moderate COVID-19

27 May, 2020 | 02:35h | UTC

Loss of Smell and Taste in 2013 European Patients With Mild to Moderate COVID-19 – Annals of Internal Medicine

 


Just the Facts: What Drugs are Safe and Effective for COVID-19?

27 May, 2020 | 02:31h | UTC

Just the Facts: What drugs are safe and effective for COVID-19? – Canadian Journal of Emergency Medicine

Related Guidelines: NIH Coronavirus Disease 2019 (COVID-19) Treatment Guidelines – National Institutes of Health AND Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19 Infection

“Apart from supportive care, there are no current effective therapeutics for COVID-19”

 


Perspective: The Totality of the Evidence, by Dr. John Ioannidis

27 May, 2020 | 02:29h | UTC

The Totality of the Evidence – Boston Review

See other interesting perspectives from the Boston Review: Models v. Evidence AND Good Science Is Good Science

“Given what we know now, it is reasonable to consider alternatives to population-wide lockdown, even as we focus on protecting those most at risk and support health care systems to care for patients who are sick.”

 


Clinical Guidance: Advanced Pulmonary and Cardiac Support of COVID-19 Patients

27 May, 2020 | 02:27h | UTC

Advanced Pulmonary and Cardiac Support of COVID-19 Patients: Emerging Recommendations From ASAIOa Living Working Document – Circulation: Heart Failure

 


A Guide to COVID-19: A Global Pandemic Caused by the Novel Coronavirus SARS-CoV-2

27 May, 2020 | 02:22h | UTC

A Guide to COVID-19: A Global Pandemic Caused by the Novel Coronavirus SARS-CoV-2 – The FEBS Journal

 


Meta-analysis: Efficacy and Safety of Convalescent Plasma for Severe COVID-19

27 May, 2020 | 02:21h | UTC

Efficacy and safety of convalescent plasma for severe COVID-19 based on evidence in other severe respiratory viral infections: a systematic review and meta-analysis – Canadian Medical Association Journal

 


Lyme Borreliosis: Diagnosis and Management

27 May, 2020 | 02:19h | UTC

Lyme borreliosis: diagnosis and management – The BMJ (free for a limited period)

 


Short Review: Using Insulin to Treat Poorly Controlled Type 2 Diabetes in 2020

27 May, 2020 | 02:18h | UTC

Using Insulin to Treat Poorly Controlled Type 2 Diabetes in 2020 – JAMA (free for a limited period)

 


Randomized Trial: Antihypertensive Medication Reduction vs. Usual Care Among Older Adults Taking Multiple Antihypertensive Medications

27 May, 2020 | 02:16h | UTC

Effect of Antihypertensive Medication Reduction vs Usual Care on Short-term Blood Pressure Control in Patients With Hypertension Aged 80 Years and Older: The OPTIMISE Randomized Clinical Trial – JAMA

Editorial: Deprescribing Antihypertensive Medications for Patients Aged 80 Years or Older: Is Doing Less Doing No Harm?

Commentary: Less is more? Deprescribing blood pressure lowering medications is safe in the short-term in older people with frailty and multiple long-term conditions – University of Oxford

 

Related Commentary on Twitter